Variability of sputum inflammatory mediators in alpha-1-antitrypsin deficiency and usual COPD Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Inflammatory mediators in COPD patients with and without alpha-1-antitrypsin deficiency Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011
Variability of sputum inflammatory mediators in COPD and ?1-antitrypsin deficiency}, Source: Eur Respir J 2012; 40: 561-569 Year: 2012
Induced sputum as a surrogate for BAL for the measurement of the monocyte/macrophage chemokines MCP-1 and MIP-1α in scleroderma fibrosing alveolitis Source: Eur Respir J 2006; 28: Suppl. 50, 309s Year: 2006
Value of induced sputum nitric oxide and 3-Nitrotyrosine(3NT) levels in differentiating obstructive and inflammatory diseases of lung Source: Eur Respir J 2003; 22: Suppl. 45, 268s Year: 2003
Proteinase 3 activity in sputum from subjects with alpha-1-antitrypsin deficiency and COPD Source: Eur Respir J 2013; 41: 1042-1050 Year: 2013
Serum TNFα and IL8 as markers of systemic inflammation in severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005
Proinflammatory cytokines in induced sputum and COPD phenotype Source: Annual Congress 2011 - COPD: human studies Year: 2011
Inflammatory mediators in nasal lavage, induced sputum and serum of employees with rheumatic and respiratory disorders Source: Eur Respir J 2001; 18: 542-548 Year: 2001
Inflammatory and regulatory cytokine IL-6 in plasma and BAL fluid of patients with pulmonary sarcoidosis Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009
Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015
Neutrophil inflammation of large airways in alpha 1-antityrpsin deficiency Source: Eur Respir J 2002; 20: Suppl. 38, 282s Year: 2002
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011
Relationship between inflammatory mediators in induced sputum and BODE-index in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007
The concentration of inflammatory cytokines in exhaled breath condensate in children with inflammatory bowel diseases Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Investigation of alarmins, interleukin (IL-)23 and IL-36 sputum levels in chronic airway obstructive diseases. Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019
Association of sputum chitinase like protein levels with pathophysiology and neutrophilic airway inflammation in asthma Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008
Proinflammatory cytokines production in patients with purulent destructive lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 105s Year: 2001
Alveolar macrophage oxidative and pro-inflammatory cytokine activity in lung sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 332s Year: 2005
Pattern of bronchial colonization and inflammatory response in patients with bronchiectasis and immunoglobulin deficiency (Igdef) Source: Eur Respir J 2001; 18: Suppl. 33, 466s Year: 2001